← All organizations

Phoenix Molecular Imaging

Academic/Hospital

Also known as: Medical Director, Phoenix Molecular Imaging

Highest phase reached

Phase 3

First clinical trial

Apr 1, 2011

Last known activity

May 1, 2014

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Recent trials (9)

  • NCT01961934Overall official - principal investigatorPhase 2/Phase 3May 1, 2014
  • NCT01961934Lead sponsorPhase 2/Phase 3May 1, 2014
  • NCT01961934Reponsible party - principal investigatorPhase 2/Phase 3May 1, 2014
  • NCT01530269Reponsible party - principal investigatorPhase 2Apr 1, 2012
  • NCT01530269Overall official - principal investigatorPhase 2Apr 1, 2012
  • NCT01530269Lead sponsorPhase 2Apr 1, 2012
  • NCT01304485Overall official - principal investigatorPhase 2Apr 1, 2011
  • NCT01304485Lead sponsorPhase 2Apr 1, 2011
  • NCT01304485Reponsible party - principal investigatorPhase 2Apr 1, 2011

Details

Last known activity
May 1, 2014